Select Page

Dr. Paul Fernyhough

Director,
Division of Neurodegenerative Disorders

Principal Investigator,
Cell Biology of Neurodegeneration Lab, Division of Neurodegenerative Disorders

Professor
Pharmacology & Therapeutics, University of Manitoba

Division of Neurodegenerative Disorders

The Division of Neurodegenerative Disorders (DND) is housed within the Dr. John Foerster Centre for Health Research on Aging, located in the St-Boniface Hospital Albrechtsen Research Centre. DND was established in 1999 through a major funding initiative “Age of Discovery” by the St-Boniface Hospital Foundation. All faculty in DND hold academic positions in theDepartment of Pharmacology & Therapeutics, University of Manitoba.

Ella Thomson earns $30K Order of the White Rose scholarship

(From UM Today Alumni) On December 1, 2017, Polytechnique Montréal presented the third annual Order of the White Rose scholarship to Ella Thomson, an electrical engineering graduate of the University of Manitoba. This $30,000 scholarship, created three years ago, is...

St. B Researchers highlighted on CTV’s MEDICALWATCH

Two St. Boniface Hospital Researchers have recently been highlighted on CTV’s “MEDICALWATCH”, hosted by reporter Michelle Gerwing: Dr. Gordon Glazner, Principal Investigator, Cellular Neuropathology & Neurodegeneration, Division of...

Merit award for Albensi

Congratulations to Dr. Ben Albensi, Principal Investigator, Synaptic Plasticity and Cellular Memory Dysfunction Lab, Division of Neurodegenerative Disorders, on receiving a merit award for Research, Teaching, and Service from the University of Manitoba and the...

St. Boniface Hospital Research celebrates World Alzheimer’s Day

Every year on September 21st, Alzheimer’s organizations around the world concentrate their efforts on raising awareness about Alzheimer’s and dementia. St. Boniface Hospital Albrechtsen Research Centre is home to world-class Alzheimer’s research!...

Fernyhough group to get SPOR funding

A St. Boniface Hospital Research team has received funding to develop a SPOR (Strategy for Patient-Oriented Research) network. The SPOR Network in Diabetes and Its Related Complications is intended to transform the health outcomes of people with diabetes and its...

Albensi accepted to CCNA

Dr. Benedict Albensi, Principal Investigator, Synaptic Plasticity and Cellular Memory Dysfunction Lab, Division of Neurodegenerative Disorders, has been accepted to the Canadian Consortium on Neurodegeneration in Aging (CCNA). The CCNA provides the infrastructure and...